Study title:
J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):743-8.
Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in
localising the epileptogenic cortex.
Lamusuo S, Ruottinen HM, Knuuti J, HärkÃnen R, Ruotsalainen U, Bergman J,
Haaparanta M, Solin O, Mervaala E, Nousiainen U, Jääskeläinen S, Ylinen A,
Kälviäinen R, Rinne JK, Vapalahti M, Rinne JO.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases [C10]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|